Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
clinical trials
drugs
5
×
fda
5
×
life sciences
national blog main
eli lilly
indiana blog main
indiana top stories
new york blog main
san diego blog main
san diego top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
investing
national
national top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
amgen
astrazeneca
bristol-myers squibb
calcitonin gene-related peptide
cancer
What
drug
5
×
fda
approval
approved
bio
class
companies
disease
medicines
migraine
new
roundup
won
year
alzheimer’s
announced
annual
arguments
assessed
attention
bacteria
big
biopharma
biotech
business
commercialized
communities
company
competitors
conference
decades
decision
developed
digital
drugs
eli
epidemic
esmo
europe
exited
Language
Current search:
fda
×
drug
×
biotech
×
drugs
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines